Apheris Gains Momentum with Pharma Pivot in 2023
Apheris's 2023 pivot to pharma and life sciences sparks a fourfold revenue surge. Discover how this strategic shift is transforming the company.
Topic
pharma
A collection of 4 issues
Novo Nordisk's $70 Billion Market Cap Loss in 2023
Explore how Novo Nordisk, a leading pharma giant, faced a significant $70 billion market capitalization loss this year. Discover the factors behind this downturn.
Eli Lilly Expands While Novo Nordisk Faces Obesity Drug Market Challenges
Eli Lilly's expansion and Novo Nordisk's struggles underscore the volatility in the obesity drug market, impacting healthcare and pharma sectors.
Obesity Drugs: The Rising Star in Pharma
Explore the booming trend of obesity drugs in the pharmaceutical sector, offering high stakes and immense market potential. Discover key insights now.